glutathione mutations in sclc patients NRF2 supports non-small cell lung cancer growth independently of CBP/p300-enhanced synthesis | EMBO Reports Frontiers | Targeting lung cancer:
Frontiers Targeting lung cancer: synergistic therapeutic strategy of cuproptosis and immunogenic cell death Differential KEAP1 NRF2 mediated signaling widens the therapeutic window of redox targeting drugs in SCLC therapy Nature Communications Glutathione Depletion and Stalwart Anticancer Activity of Metallotherapeutics Inducing Programmed Cell Death: Opening a New Window for Cancer Therapy ACS Omega JCI Suppression of the SLC7A11 glutathione axis causes synthetic lethality in KRAS mutant lung adenocarcinoma Impact of the deletion glutathione S transferase (class Mu) on lung cancer risk among smokers The Egyptian Journal of Bronchology Springer Nature Link Immunotherapy in small cell lung cancer: from molecular promises to clinical challenges Journal for ImmunoTherapy of Cancer
Pay in 4 interest-free payments of $6.01 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 5 - Aug 10





